Author

Alejandro Romero

Observed names: A Romero, A. Romero, A. Romero., Alejandro Romero Martínez, Romero, Alejandro, alejandro Romero

Institution: Universidad Complutense de Madrid

Observed institutions: Universidad Complutense de Madrid, Universitat Autònoma de Barcelona, Consejo Superior de Investigaciones Científicas, United Arab Emirates University, Instituto Cajal, Hospital Universitario La Paz, University of Florida, Hospital La Paz Institute for Health Research, Universidade de Vigo, Universidad Autónoma de Madrid

ORCID: 0000-0001-5483-4973

Observed ORCID: 0000-0001-5483-4973

OpenAlex ID: A5017542552

Influence of the extraction method on the recovery of bioactive phenolic compounds from food industry by-products

2021 · Emilio Gil-Martín, Tamara Forbes-Hernández, et al. · Food Chemistry · 720

PDF

Permethrin-induced oxidative stress and toxicity and metabolism. A review

2016 · Xu Wang, María-Aránzazu Martínez, et al. · Environmental Research · 263

A review of metal‐catalyzed molecular damage: protection by melatonin

2014 · Alejandro Romero, Eva Ramos, et al. · Journal of Pineal Research · 177

Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease

2013 · Alejandro Romero, Ramón Cacabelos, et al. · Bioorganic & Medicinal Chemistry Letters · 160

A History of the Pharmacological Treatment of Bipolar Disorder

2018 · Francisco López-Muñoz, Winston W. Shen, et al. · International Journal of Molecular Sciences · 158

PDF

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

2014 · Li Wang, Gerard Esteban, et al. · European Journal of Medicinal Chemistry · 145

Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway

2012 · Tharine Dal-Cim, Simone Molz, et al. · Neurochemistry International · 115

PDF

The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators

2016 · Mohamed Benchekroun, Alejandro Romero, et al. · Journal of Medicinal Chemistry · 110

Mycotoxins modify the barrier function of Caco-2 cells through differential gene expression of specific claudin isoforms: Protective effect of illite mineral clay

2016 · Alejandro Romero, Irma Ares, et al. · Toxicology · 110

Neuroprotective effect of melatonin against ischemia is partially mediated by alpha‐7 nicotinic receptor modulation and HO ‐1 overexpression

2013 · Esther Parada, Izaskun Buendia, et al. · Journal of Pineal Research · 108

Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases

2017 · Óscar M. Bautista‐Aguilera, Stefanie Hagenow, et al. · Angewandte Chemie International Edition · 105

Ischemic brain injury: New insights on the protective role of melatonin

2017 · Eva Ramos, Paloma Patiño, et al. · Free Radical Biology and Medicine · 94

Fipronil sulfone induced higher cytotoxicity than fipronil in SH-SY5Y cells: Protection by antioxidants

2016 · A. Romero, E. Ramos, et al. · Toxicology Letters · 89

New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease

2014 · Beatriz López-Iglesias, Concepción Pérez, et al. · Journal of Medicinal Chemistry · 89

Cytotoxicity induced by deltamethrin and its metabolites in SH-SY5Y cells can be differentially prevented by selected antioxidants

2012 · Alejandro Romero, Eva Ramos, et al. · Toxicology in Vitro · 85

Neuroprotective effect of guanosine against glutamate‐induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol‐3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition

2011 · Simone Molz, Tharine Dal‐Cim, et al. · Journal of Neuroscience Research · 83

Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway

2010 · Esther Parada, Javier Egea, et al. · Free Radical Biology and Medicine · 81

Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH‐SY5Y neuroblastoma cells

2010 · Alejandro Romero, Javier Egea, et al. · Journal of Pineal Research · 81

Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives

2010 · Cristóbal de los Ríos, Javier Egea, et al. · Journal of Medicinal Chemistry · 79

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy

2016 · José Marco-Contelles, Mercedes Unzeta, et al. · Frontiers in Neuroscience · 77

PDF

Novel Tacrine‐Grafted Ugi Adducts as Multipotent Anti‐Alzheimer Drugs: A Synthetic Renewal in Tacrine–Ferulic Acid Hybrids

2014 · Mohamed Benchekroun, Manuela Bartolini, et al. · ChemMedChem · 75

The emergence of melatonin in oncology: Focus on colorectal cancer

2019 · Emilio Gil‐Martín, Javier Egea, et al. · Medicinal Research Reviews · 71

Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease

2012 · Emna Maalej, Fakher Chabchoub, et al. · European Journal of Medicinal Chemistry · 69

2023 · Russel J. Reiter, Ramaswamy Sharma, et al. · Antioxidants · 66

PDF

Oxidative stress and gene expression profiling of cell death pathways in alpha-cypermethrin-treated SH-SY5Y cells

2016 · Alejandro Romero, Eva Ramos, et al. · Archives of Toxicology · 62

Works count: 160

Citation count: 5,442

H-index: 43

I10-index: 94